Genetics of Atopic Dermatitis

1. ALAM, R. Chemokines in allergic inflammation. J. Allergy

Clin. Immunology, 1997, 99, p. 273–277.

2. ARIMA, K., UMESHITA-SUYAMA, R., SAKATA, Y.,

AKAIWA, M., MAO, XQ., ENOMOTO, T., DAKE, Y.,

SHIMAZU, S., YAMASHITA, T., SUGAWARA, N. et al.

Upregulation of IL-13 concentration in vivo by the IL13 variant

associated with bronchial asthma. J. Allergy Clin.

Immunol., 2002, 109, p. 980–987.

3. BADERTSCHER, K., BRONNIMANN,M., KARLEN, S.,

BRAATHEN, L. R.,YAWALKAR, N.Mast cell chymase is

increased in chronic atopic dermatitis but not in psoriasis.

Arch. Dermatol. Res., 2005, 296, p. 503–506.

4. BAI, B., TANAKA, K., TAZAWA, T., YAMAMOTO, N.,

SUGIURA, H.Association between RANTES promoter polymorphism

– 401A and enhanced RANTES production in

atopic dermatitis patients. J. Dermatol. Sci., 2005, 39,

p. 189–191.

5. BARNES, K. C. Gene-environment and gene-gene interaction

studies in the molecular genetic analysis of asthma and

atopy. Clin. Exp. Allergy, 1999, 29, 4, p. 47–51.

6. BAZAREL,M., ORGEL, H.A., HAMBURGER, R. N. IgE

levels in normal infants and mothers and an inheritance hypothesis.

J. Immunol., 1971, 107, p. 794–801.

7. BEYER, K., NICKEL, R., FREIDHOFF, L., BJORKSTEN,

B., HUANG, S. K., BARNES, K. C. et al. Association and

linkage of atopic dermatitis with chromosome 13q12-14 and

5q31-33 markers. J. Invest. Dermatol., 2000, 115,

p. 906–908.

8. BRADLEY, M., SODERHALL, C., LUTHMAN, H.,

WAHLGREN, C. F., KOCKUM, I., NORDENSKJOLD,M.

Susceptibility loci for atopic dermatitis on chromosomes 3,

13, 15, 17 and 18 in a Swedish population. Hum. Mol. Genet.,

2002, 11, p. 1539–1548.

9. CHAVANAS, S., BODEMER, C., ROCHAT, A., HAMELTEILLAC,

D., ALI, M., IRVINE, A. D., BONAFE, J. L.,

WILKINSON, J., TAIEB,A., BARRANDON, Y. et al.Mutations

in SPINK5, encoding a serine protease inhibitor, cause

Netherton syndrome. Nat. Genet., 2000, 25, p. 141–142.

10. CHRISTENSEN, U., MOLLER-LARSEN, S., NYEGAARD,

M., HAAGERUP, A., HEDEMAND, A., BRASCHANDERSEN,

C. et al. Linkage of atopic dermatitis to chromosomes

4q22, 3p24 and 3q21. Hum. Genet., 2009, 126,

p. 549–557.

11. CHROMEJ, I. Atopick˘ ekzém. 1. vydanie Banská Bystrica:

Dali-BB, 2007, 240 s., ISBN 9788089090259.

12. COOKSON, W. O., UBHI, B., LAWRENCE, R., ABECASIS,

G. R., WALLEY, A. J., COX, H. E. et al. Genetic

linkage of childhood atopic dermatitis to psoriasis susceptibility

loci. Nat. Genet., 2001, 27, p. 372–373.

13. COOKSON, W. O., YOUNG, R. P., SANDFORD, A. J.,

MOFFATT,M. F., SHIRAKAWA, T., SHARP, P. A., FAUX,

J. A., JULIER, C., NAKUMUURA, Y., NAKUMURA, Y.

et al. Maternal inheritance of atopic IgE responsiveness on

chromosome 11q. Lancet, 1992, 340 (8816), p. 381–384.

14. COOKSON, W. O., UBHI, B., LAWRENCE, R., ABECASIS,

G. R., WALLEY, A. J., COX, H. E. et al. Genetic

linkage of childhood atopic dermatitis to psoriasis susceptibility

loci. Nat. Genet., 2001, 27, p. 72–73.

15. COOKSON, W. O., MOFFATT, M. F. Genetics of asthma

and allergic disease. Hum. Mol. Genet., 2000, 9,

p. 2359–2364.

16. COOKSON, W. The aliance of genes and environment in

astma and allergy. Nature, 1999, 402, p. 5–11.

17. COX, H. E., MOFFATT, M. F., FAUX, J. A., WALLEY,

A. J., COLEMAN, R., TREMBATH, R. C. et al. Association

of atopic dermatitis to the beta subunit of the high affinity

immunoglobulin E receptor. Br. J. Dermatol., 1998,

138, p. 182–187.

18. ENOMOTO, H., NOGUCHI, E., IIJIMA, S., TAKAHASHI,

T., HAYAKAWA, K., ITO, M. et al. Single nucleotide

polymorphism-based genome-wide linkage analysis in Japanese

atopic dermatitis families. BMC Dermatol., 2007, 7,

p. 5.

19. FOLSTER-HOLST, R., STOLL, M., KOCH, WA., HAMPE,

J., CHRISTOPHERS, E., SCHREIBER, S. Lack of association

of SPINK5 polymorphisms with nonsyndromic

atopic dermatitis in the population of Northern Germany. Br.

J. Dermatol., 2005, 152, p. 1365–1367.

20. FORREST, S., DUNN, K., ELLIOTT, K., FITZPATRICK,

E., FULLERTON, J.,MCCARTHY,M. et al. Identifying genes

predisposing to atopic eczema. J. Allergy Clin. Immunol.,

1999, 104, p. 1066–1070.

21. GARMAN, S. C., KINET, J. P., JARDETZKY, T. S. Crystal

structure of the human high-affinity IgE receptor. Cell, 1998,

95, p. 951–961.

22. GRAVES, P. E., KABESCH, M., HALONEN, M., HOLBERG,

C. J., BALDINI, M., FRITZSCH, C., WEILAND,

S. K., ERICKSON, R. P., VON MUTIUS, E., MARTINEZ,

F. D.A cluster of seven tightly linked polymorphisms in the

IL-13 gene is associated with total serum IgE levels in three

populations of white children. J. Allergy Clin. Immunol.,

2000, 105, p. 506–513.

23. GUILLOUD-BATAILLE, M., BOUZIGON, E., ANNESIMAESANO,

I., BOUSQUET, J., CHARPIN, D., GORMAND,

F. et al. Evidence for linkage of a new region

(11p14) to eczema and allergic diseases. Hum. Genet., 2008,

122, p. 605–614.

24. HAAGERUP, A., BJERKE, T., SCHIOTZ, P. O., DAHL,

R., BINDERUP, H. G., TAN, Q. et al. Atopic dermatitis –

a total genome-scan for susceptibility genes. Acta Derm. Venereol.,

2004, 84, p. 346–352.

25. HE, S.,WALLS,A. F. The induction of a prolonged increase

in microvascular permeability by human mast cell chymase.

Eur. J. Pharmacol., 1998, 352, p. 91–98.

26. HE, S., WALLS, A. F. Human mast cell chymase induces

the accumulation of neutrophils, eosinophils and other inflammatory

cells in vivo. Br. J. Pharmacol., 1998, 125,

p. 1491–1500.

27. HE, J. Q., CHAN-YEUNG,M., BECKER,A. B., DIMICHWARD,

H., FERGUSON, A. C., MANFREDA, J., WATSON,

W. T., SANDFORD,A. J. Genetic variants of the IL13

and IL4 genes and atopic diseases in at-risk children. Genes.

Immun., 2000, 4, p. 385–389.

28. HEINZMANN, A., MAO, X. Q., AKAIWA, M., KREOMER,

R. T., GAO, P. S., OHSHIMA, K., UMESHITA, R.,

ABE, Y., BRAUN, S., YAMASHITA, T. et al. Genetic variants

of IL-13 signalling and human asthma and atopy. Hum.

Mol. Genet., 2000, 9, p. 549–559.

29. HENDERSON, J., NORTHSTONE, K., LEE, S. P., LIAO,

H., ZHAO, Y., PEMBREY, M. et al. The burden of disease

associated with filaggrin mutations: a population-based, longitudinal

birth cohort study. J. Allergy Clin. Immunol., 2008,

121, p. 872–877.

30. HOWARD, T. D., WHITTAKER, P. A., ZAIMAN, A. L.,

KOPPELMAN, G. H., XU, J., HANLEY, M. T.,MEYERS,

D. A., POSTMA, D. S., BLEECKER, E. R. Identification

and association of polymorphisms in the interleukin-13 gene

with asthma and atopy in a Dutch population. Am. J. Respir.

Cell Mol. Biol., 2001, 25, p. 377–384.

31. HUMMELSHOJ, T., BODTGER, U., DATTA, P., MALLING,

H. J., OTURAI,A., POULSEN, L. K., RYDER, L. P.,

SORENSEN, P. S., SVEJGAARD, E., SVEJGAARD,

A. Association between an interleukin-13 promoter polymorphism

and atopy. Eur. J. Immunogenet., 2003, 30,

p. 355–359.

32. JAMES, A., MACLEAN, M. D., FRANK, J. EIDELMAN,

M. D. The Genetics of Atopy and Atopic Eczema.

Arch. Dermatol., 2001, 137, p. 1474–1476.

33. KABESCH, M., CARR, D.,WEILAND, S. K., von MUTIUS,

E.Association between polymorphisms in serine protease

inhibitor, kazal type 5 and asthma phenotypes in a large

German population sample. Clin. Exp. Allergy, 2004, 34,

p. 340–345.

34. KATO, A., FUKAI, K., OISO, N., HOSOMI, N., MURAKAMI,

T., ISHII, M. Association of SPINK5 gene polymorphisms

with atopic dermatitis in the Japanese population.

Br. J. Dermatos., 2003, 148, p. 665–669.

35. KOFFORD, M. W., SCHWARTZ, L. B., SCHECHTER,

N. M., YAGER, D. R., DIEGELMANN, R. F., GRAHAM,

M. F. Cleavage of type I procollagen by human mast

cell chymase initiates collagen fibril formation and generates

a unique carboxyl- terminal propeptide. J. Biol. Chem.,

1997, 272, p. 7127–7131.

36. KOZMA, G. T., FALUS, A., BOJSZKO, A., KRIKOVSZKY,

D., SZABO, T., NAGY, A. et al. Lack of association

between atopic eczema/dermatitis syndrome and polymorphisms

in the promoter region of RANTES and regulatory

region of MCP-1. Allergy, 2002, 57, p. 160–163.

37. LARSEN, F. S., HOLM, N. V., HENNINGSEN, K. Atopic

dermatitis. A genetic-epidemiologic study in a populationbased

twin sample. J. Am. Acad. Dermatol., 1986, 15,

p. 487–494.

38. LEE, Y. A.,WAHN, U., KEHRT, R., TARANI, L., BUSINCO,

L., GUSTAFSSON, D. et al. A major susceptibility locus

for atopic dermatitis maps to chromosome 3q21. Nat.

Genet., 2000, 26, p. 470–473.

39. LIU, X., NICKEL, R., BEYER, K.,WAHN, U., EHRLICH,

E., FREIDHOFF, L. R., BJORKSTEN, B., BEATY, T. H.,

HUANG, S. K. An IL13 coding region variant is associated

with a high total serum IgE level and atopic dermatitis in the

German multicenter atopy study (MAS-90). J. Allergy Clin.

Immunol., 2000, 106, p. 167–170.

40. MAO, X. Q., SHIRAKAWA, T., YOSHIKAWA, T., YOSHIKAWA,

K., KAWAI, M., SASAKI, S. et al. Association

between genetic variants of mast-cell chymase and eczema.

Lancet, 1996, 348, p. 581–583.

41. MEYERS, D., BLEECKER, E. Genetics of allergic disease.

In Allergy: Principles & Practice. 5th ed. St. Louis, Mo:

Mosby–Year Book Inc, 1998, p. 40–45.

42. MORAR, N., WILLIS-OWEN, S. A., MOFFATT M. F.,

COOKSON,W. O. The genetics of atopic dermatitis. J. Allergy

Clin. Immunol., 2006, 118, 1, p. 24–34.

43. NICKEL, R. G., CASOLARO, V.,WAHN, U., BEYER, K.,

BARNES, K. C., PLUNKETT, B. S. et al. Atopic dermati

tis is associated with a functional mutation in the promoter

of the C-C chemokine RANTES. J. Immunol., 2000, 164,

p. 1612–1616.

44. ON,M., BILLINGSLEY, J.M., JOUVIN,M. H., KINET, J.

P. Molecular dissection of the FcRbeta signaling amplifier.

J. Biol. Chem., 2004, 279, 45, p. 782–790.

45. PASCALE, E., TARANI, L., MEGLIO, P., BUSINCO, L.,

BATTILORO, E., CIMINO-REALE, G., VERNA, R.,

D’AMBROSIO, E. Absence of association between

a variant of the mast cell chymase gene and atopic dermatitis

in an Italian population. Hum. Hered., 2001, 51, 3,

p. 177–179.

46. SCHULTZ-LARSEN, F. V., HOLM, N. V. Atopic dermatitis

in a population based twin series. Concordance rates and

heritability estimation. Acta Derm. Venereol. Suppl., 1985,

114, p. 159.

47. SMITH, D. L., SMITH, J. G., WONG, S. W., DESHAZO,

R. D. Netherton’s syndrome: a syndrome of elevated IgE

and characteristic skin and hair findings. J. Allergy Clin. Immunol.,

1995, 95, p. 116–123.

48. SMITH, F. J., IRVINE,A. D., TERRON-KWIATKOWSKI,

A. et al. Loss-of-function mutations in the gene encoding filaggrin

cause ichthyosis vulgaris. Nat. Genet., 2006, 38,

p. 337–342.

49. SODERHALL, C., BRADLEY,M., KOCKUM, I.,WAHLGREN,

C. F., LUTHMAN, H., NORDENSKJOLD, M.

Linkage and association to candidate regions in Swedish

atopic dermatitis families. Hum. Genet., 2001, 109,

p. 129–135.

50. TAIPALE, J., LOHI, J., SAARINEN, J., KOVANEN, P. T.,

KESKI-OJA, J. Human mast cell chymase and leukocyte

elastase release latent transforming growth factor-beta 1

from the extracellular matrix of cultured human epithelial

and endothelial cells. J. Biol. Chem., 1995, 270,

p. 4689–4696.

51.TSUNEMI,Y., SAEKI, H., NAKAMURA, K., SEKIYA, T.,

52.HIRAI, K., FUJITA, H. et al. Eotaxin gene single nucleotide

polymorphisms in the promoter and exon regions are not

associated with susceptibility to atopic dermatitis, but two of

them in the promoter region are associated with serum IgE

levels in patients with atopic dermatitis. J. Dermatol. Sci.,

2002, 29, p. 222–228.

52. TSUNEMI,Y., SAEKI, H., NAKAMURA, K., SEKIYA, T.,

HIRAI, K., KAKINUMA, T., FUJITA, H.,ASANO, N., TANIDA,

Y.,WAKUGAWA, M. et al. Interleukin-13 gene polymorphism

G4257Ais associated with atopic dermatitis in

Japanese patients. J. Dermatol. Sci., 2002, 30, p. 100–107.

53. VAN DER POUW KRAAN, T. C., VAN VEEN, A.,

BOEIJE, L. C., VAN TUYL, S. A, DE GROOT, E. R.,

STAPEL, S. O., BAKKER, A., VERWEIJ, C. L.,

AARDEN. L. A, VAN DER ZEE. J. S. An IL-13 promoter

polymorphism associated with increased risk of allergic

asthma. Genes Immun., 1996, 1, p. 61–65.

54. WALLEY, A. J., CHAVANAS, S., MOFFATT, M. F.,

ESNOUF, R M., UBHI, B., LAWRENCE, R., WONG, K.,

ABECASIS, G. R., JONES, E. Y., HARPER, J. I. et al. Gene

polymorphism in Netherton and common atopic disease.

Nat. Genet., 2001, 29, p. 175–178.

55. YAWALKAR, N., UGUCCIONI, M., SCHARER, J.,

BRAUNWALDER, J., KARLEN, S., DEWALD, B. et al.

Enhanced expression of eotaxin and CCR3 in atopic dermatitis.

J. Invest. Dermatol., 1999, 113, p. 43–48.